Tenax Therapeutics Income Statement (2010-2026) | TENX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	0.69M	1.16M	0.92M	1.18M	1.52M	1.54M	1.13M	0.27M	0.20M	1.07M	1.70M	2.68M	2.33M	3.11M	4.59M	5.68M	6.12M	10.33M	10.54M	11.54M
Selling, General & Administrative (Quarter)	1.27M	2.64M	2.30M	1.54M	1.34M	1.38M	1.42M	1.27M	1.04M	1.05M	1.64M	1.23M	1.34M	1.51M	2.70M	5.66M	5.67M	6.48M	5.91M	5.03M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	-0.25M	-0.00M	-0.00M	310.00	-0.00M
Operating Expenses (Quarter)	1.96M	3.80M	3.21M	2.72M	2.86M	2.92M	2.55M	1.54M	1.24M	2.12M	3.34M	3.91M	3.67M	4.62M	7.29M	11.34M	11.79M	16.81M	16.45M	16.57M
Operating Income (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.54M	1.24M	2.12M	-13.13M	-3.91M	-3.67M	-4.62M	-7.29M	-11.34M	-11.79M	-16.81M	-16.45M	-16.57M
EBIT (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.54M	1.24M	2.12M	-13.13M	-3.91M	-3.67M	-4.62M	-7.29M	-11.34M	-11.79M	-16.81M	-16.45M	-16.57M
Non-operating items
Non Operating Investment Income (Quarter)	-128.00	-276.00	2.00
Interest & Investment Income (Quarter)					63.00				0.14M	-0.15M	0.85M	0.12M	0.10M	0.67M	1.03M	0.93M	0.95M	1.02M	0.92M	0.86M
Other Non Operating Income (Quarter)	-0.25M	0.00M	0.00M	310.00	-0.00M	-0.00M	-0.01M	-0.14M	911.00		0.13M	-0.12M	0.00M		0.00M		-0.01M	-0.01M	-0.01M	-0.00M
Non Operating Income (Quarter)	-0.25M				-0.00M	-0.00M	-0.01M	-0.14M	911.00		0.13M	-0.12M	0.00M		0.00M		-0.01M	-0.01M	-0.01M	-0.00M
Net income details
EBT (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Profit After Tax (Quarter)	-1.72M	3.80M	-61.74M	-2.72M	-2.86M	2.92M	2.55M	-1.41M	-1.11M	1.97M	-12.19M	-3.80M	-3.58M	-3.96M	-6.30M	-10.40M	-10.85M	-15.80M	-15.50M	-15.70M
Income from Continuing Operations (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Consolidated Net Income (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Income towards Parent Company (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Additional items
EPS (Basic) (Quarter)	-0.10	-0.15	-0.04	0.27	1.66	2.22	129.66	-13.30	4.94	6.58	-623.45	-3.12	-1.83	-0.19	0.22	-0.28	-0.27	-0.40	-0.38	-0.35
EPS (Weighted Average and Diluted) (Quarter)											-49.42	-3.12	-1.83	-0.19	0.22	-0.28	-0.27	-0.40	-0.38	-0.35
Shares Outstanding (Weighted Average) (Quarter)	17.22M	10.03M	0.01M	10.03M	1.72M	1.32M	0.02M	0.12M	0.28M	0.30M	0.02M	3.22M	1.96M	19.89M	15.27M	19.80M	38.09M	19.08M	16.90M	45.23M
Shares Outstanding (Diluted Average) (Quarter)											0.25M	1.22M	1.59M	8.28M	15.27M	36.58M	38.09M	39.74M	39.22M	45.23M
EBITDA (Quarter)	1.72M	3.80M	-61.74M	2.72M	2.86M	2.92M	2.55M	-1.54M	1.24M	2.12M	-13.13M	-3.91M	-3.67M	-4.62M	-7.29M	-11.34M	-11.79M	-16.81M	-16.45M	-16.57M
Interest Expenses (Quarter)	336.00			0.00M	0.00M	372.00		0.01M	0.01M	0.01M	0.00M	0.01M	0.01M	0.01M	-0.00M
Shares Outstanding (Quarter)	25.20M	25.20M	0.02M	1.26M	1.26M	6.03M	0.03M	210.00	0.30M	0.30M	0.30M	1.96M	1.96M	210.00	3.42M	210.00	210.00	5.91M	9.31M	24.28M

Research Tools

Tenax Therapeutics Income Statement (2010-2026) | TENX

Create an account

Sign In

Reset Password